Knowledge Center
Poster / Dec 06, 2017
Spray Dried Composite Particles: Formulation and Process Parameters, Effect of two API Concentrations and Stability Assessment
Source:
DDL 2017
In dry powders for inhalation the active pharmaceutical ingredient (API) is typically blended with excipients. However, poor drug delivery uniformity is frequently observed and the addition of a second API further increase the complexity of the formulation. In order to overcome these challenges, the engineering of carrier-free composite particles by spray drying (SD) is a suitable alternative.
Related links
Also in the Knowledge Center
/ Dec 28, 2016
Continuous production of particles, micro- and/or nanoparticles, particulate amorphous solid dispersions, particulate co-crystals and pharmaceutical compns.
Read more
Scientific Article
/ Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Read more
Scientific Article
/ Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Read more
Scientific Article